Author Information
Johnny Huard is affiliated with the Department of Orthopaedic Surgery at McGovern Medical School, University of Texas Health Science Center at Houston, and the Steadman Philippon Research Institute in Vail, CO, United States of America. His research primarily focuses on orthopaedic surgery, cartilage repair, stem cell therapy, and aging-related studies.Research Contributions
Johnny Huard has made significant contributions to the fields of orthopaedics, stem cell therapy, and aging. In 2022 alone, he has published several influential papers, including studies on chondroprogenitors derived from human pluripotent stem cells, the therapeutic effects of VEGF-attenuated platelet-rich plasma on cartilage repair, and strategies to reduce the risk of revision surgeries in hip arthroscopy. His research extends to understanding the effects of oral losartan on articular cartilage and bone homeostasis, and the use of genome-engineered muscle-derived stem cells for anti-inflammatory and antifibrotic activities. In 2021, his work focused on the aging immune system, intra-articular injection of Bevacizumab for cartilage repair, and the role of senescence in joint homeostasis. Additionally, he has explored the potential of small molecule inhibitors and mesenchymal stem cell-derived extracellular vesicles to reduce markers of senescence and improve healthspan in mouse models of aging.Aliases
J Huard, J. Huard, Johnny HuardPublication and Citation Metrics
| Citation Count |
34,880 |
| h-index |
102 |
| Paper Count |
644 |
